207 related articles for article (PubMed ID: 1762684)
41. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
Minematsu N
Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
[TBL] [Abstract][Full Text] [Related]
42. Effect of daily dose of chronic haloperidol and chronic apomorphine on behavioral hypersensitivity in the rat.
Kinon BJ; Merson D; Kane JM
Psychopharmacology (Berl); 1984; 84(3):347-51. PubMed ID: 6440181
[TBL] [Abstract][Full Text] [Related]
43. Diazepam attenuates the antagonism of haloperidol against apomorphine-induced stereotypic behavior after subchronic but not acute treatment in rats.
Fuchs V; Coper H; Strauss S; Rommelspacher H
Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):133-7. PubMed ID: 3024028
[TBL] [Abstract][Full Text] [Related]
44. Differential alteration in striatal dopaminergic and cortical serotonergic receptors induced by repeated administration of haloperidol or centbutindole in rats.
Gulati A; Srimal RC; Dhawan BN
Pharmacology; 1988; 36(6):396-404. PubMed ID: 2901759
[TBL] [Abstract][Full Text] [Related]
45. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
46. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats.
Bhargava HN
Neuropharmacology; 1984 Apr; 23(4):439-44. PubMed ID: 6145116
[TBL] [Abstract][Full Text] [Related]
47. Prolonged inhibition of striatal dopamine receptor sites by isofloxythepin.
Lau YS; Runice C
Eur J Pharmacol; 1985 Oct; 116(1-2):25-31. PubMed ID: 2865162
[TBL] [Abstract][Full Text] [Related]
48. Enhancement of hypophysectomy-induced dopamine receptor hypersensitivity in male rats by chronic haloperidol administration.
Gordon JH; Diamond BI
J Neurochem; 1984 Feb; 42(2):523-8. PubMed ID: 6537969
[TBL] [Abstract][Full Text] [Related]
49. Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol.
Bannon MJ; Bunney EB; Zigun JR; Skirboll LR; Roth RH
Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):161-5. PubMed ID: 6772975
[TBL] [Abstract][Full Text] [Related]
50. Molindone compared to haloperidol in a guinea-pig model of tardive dyskinesia.
Koller W; Curtin J; Fields J
Neuropharmacology; 1984 Oct; 23(10):1191-4. PubMed ID: 6240609
[TBL] [Abstract][Full Text] [Related]
51. Blockade of both D1- and D2-dopamine receptors inhibits amphetamine-induced ascorbate release in the neostriatum.
Oh C; Gardiner TW; Rebec GV
Brain Res; 1989 Feb; 480(1-2):184-9. PubMed ID: 2565749
[TBL] [Abstract][Full Text] [Related]
52. The effect of chronic L-dopa administration on supersensitive pre- and postsynaptic dopaminergic receptors in rat brain.
Reches A; Wagner HR; Jiang D; Jackson V; Fahn S
Life Sci; 1982 Jul; 31(1):37-44. PubMed ID: 7109853
[TBL] [Abstract][Full Text] [Related]
53. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.
Prosser ES; Pruthi R; Csernansky JG
Psychopharmacology (Berl); 1989; 99(1):109-16. PubMed ID: 2506596
[TBL] [Abstract][Full Text] [Related]
54. Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum.
Friend WC; Brown GM; Jawahir G; Lee T; Seeman P
Am J Psychiatry; 1978 Jul; 135(7):839-41. PubMed ID: 665797
[TBL] [Abstract][Full Text] [Related]
55. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
Davidkova G; Zhou LW; Morabito M; Zhang SP; Weiss B
J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422
[TBL] [Abstract][Full Text] [Related]
56. Diltiazem suppresses apomorphine-induced fighting and pro-aggressive effect of withdrawal from chronic ethanol or haloperidol in rats.
Pucilowski O; Kostowski W
Neurosci Lett; 1988 Oct; 93(1):96-100. PubMed ID: 3211374
[TBL] [Abstract][Full Text] [Related]
57. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation.
Carvey PM; Hitri A; Goetz CG; Tanner CM; Klawans HL
Life Sci; 1988; 42(22):2207-15. PubMed ID: 3374255
[TBL] [Abstract][Full Text] [Related]
58. Dopamine receptor-mediated spinal antinociception in the normal and haloperidol pretreated rat: effects of sulpiride and SCH 23390.
Barasi S; Ben-Sreti MM; Clatworthy AL; Duggal KN; Gonzalez JP; Robertson J; Rooney KF; Sewell RD
Br J Pharmacol; 1987 Jan; 90(1):15-22. PubMed ID: 3545350
[TBL] [Abstract][Full Text] [Related]
59. Repeated apomorphine treatment causes behavioural supersensitivity and dopamine D2 receptor hyposensitivity.
Bevan P
Neurosci Lett; 1983 Feb; 35(2):185-9. PubMed ID: 6222273
[TBL] [Abstract][Full Text] [Related]
60. Difference in catalepsy response in inbred rats during chronic haloperidol treatment is not predictive of the intensity of behavioral hypersensitivity which subsequently develops.
Kinon BJ; Kane JM
Psychopharmacology (Berl); 1989; 98(4):465-71. PubMed ID: 2505286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
